Abstract
Nitric oxide (NO) plays an important role in the pathogenesis of the histological changes seen in coeliac disease. We have investigated the effect of peptic-tryptic digest of gliadin (Pt-G) and gliadin (G) on inducible nitric oxide synthase (iNOS) protein expression in RAW 264.7 macrophages stimulated with interferon-γ (IFN-γ). Pt-G and G enhanced in a concentration and time-dependent manner NO production by IFN-γ-stimulated RAW 264.7 cells. The increase of iNOS protein expression was correlated with NF-κB/DNA binding activity and occurred at transcriptional level. Pyrrolidine dithiocarbamate and N-α-para-tosyl-L-lysine chloromethyl ketone, two known inhibitors of NF-κB activation, decreased significantly NO production and iNOS protein expression as well as NF-κB/DNA binding activity. Our results show that the effect of Pt-G and G on enhancement of iNOS protein expression in IFN-γ-treated RAW 264.7 cells is mainly mediated through NF-κB and suggest that blockage of NF-κB activation reduces enhancing effect of gluten on NO production in inflamed mucosa of coeliac patients.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Coeliac disease (CD) is an enteropathy caused by permanent intolerance to gluten/gliadin, in genetically susceptible individuals (Sollid 2000; Shan et al. 2002). The disease in its typical form is histologically characterised by a lesion in the upper small bowel (Marsh 1992). The mechanisms by which gluten/gliadin damages the intestinal mucosa of coeliac patients have not been elucidated. Different hypotheses have been proposed to explain the origin of the mucosal damage. Some reports include a direct toxic effect of gliadin on intestinal mucosa (Auricchio et al. 1990; Maiuri et al. 1996). Most observations favour a disregulated immune response to gluten-derived peptides in coeliac patients. Toxic gluten peptides are absorbed across the epithelium, presented in associated with HLA class-II molecules by macrophages in the lamina propria and recognised by gliadin antigen specific CD4+ T cells (Marsh 1992; Sollid 2000). As a result, secreted mediators, including IFN-γ, may cause activation of macrophages, which, in turn, produce pro-inflammatory cytokines contributing to the damage of the mucosal matrix (Przemioslo et al. 1994; Kontakou et al. 1995; Nilsen et al. 1995; Pender et al. 1996). It has been reported that NO may play an important role in the mucosal lesion (Beckett et al. 1998). High levels of nitric oxide products (nitrate/nitrite) in the urine of children with active CD have been correlated with the expression of iNOS in the small intestine (Holmegren Peterson et al. 1998; van Straaten et al. 1999). The promoter region of the iNOS gene has been characterised in different species, including human, rat and mouse (Xie et al. 1993; Chu et al. 1998; Eberhardt et al. 1996). Sequence analysis of promoter revealed the presence of consensus motifs for binding of transcription factors, such as nuclear factor-κB (NF-κB), interferon regulatory factor (IRF)-1 and signal transducer and activator of transcription (STAT)-1α, which are essential for the iNOS induction by IFN-γ (Kamijo et al. 1994; Martin et al. 1994; Weisz et al. 1994; Gao et al. 1997; Kim et al. 1997). It has been shown that in CD both enterocytes and cells with macrophage-like morphology in the lamina propria are responsible for increased iNOS expression (ter Steege et al. 1997). Recent report has shown that gluten or gliadin and their proteolytic fragments enhanced NO production and iNOS mRNA level in mouse peritoneal macrophages stimulated with IFN-γ (Tuckovà et al. 2000). Moreover, the molecular mechanisms by which gluten/gliadin increases NO production and iNOS expression in intestinal mucosa cells in CD and cultured activated macrophages have not been elucidated. We have investigated the effect of gluten-derived peptides, Pt-G and G, on iNOS protein expression in RAW 264.7 macrophages stimulated with IFN-γ. In the present study, we show that in these cells the enhancing effect of Pt-G and G on iNOS gene induction is mainly mediated through the NF-κB signalling pathway.
Materials and methods
Gliadin and zein digest
Pure bread wheat (Triticum aestivum, var. San Pastore) was kindly supplied by the "Istituto Sperimentale per la Cerealicoltura", Rome, Italy. Peptic-tryptic digest of gliadin (Pt-G), purified prolamin fraction, were prepared following a two-step procedure as previously described (De Ritis et al. 1979). Gliadin (100 g) pool was digested in 1 l of HCl 0.2 M (pH 1.8) with 2 g of purified pepsin at 37°C for 2 h. The resultant peptic digest was further digested by addition of 2 g of purified trypsin after pH adjustment to 8.0 with NaOH 2 M. The reaction mixture was vigorously stirred at 37°C for 4 h at pH 8.0. During the entire digestion procedure, the pH was checked periodically and when needed adjusted with HCl or NaOH. At the end of the whole digestion period, the digest was submitted to gel filtration and the peptide fractions eluted after cytocrome c were collected, freeze-dried and stored at −20°C. Zein (Z) from maize (Sigma, Milan, Italy), was extracted from commercial preparations with 70% (v/v) ethanol and freeze-dried. Z (1 g) was dissolved in 10 ml of HCl 0.1 M. Pepsin (20 mg) was added and after digestion for 4 h at 37°C, pH was adjusted to 8.0 by NaOH 5.0 M. The zein was then further digested with 20 mg trypsin at 37°C for 4 h. Inactivation of trypsin was achieved by heating at 90°C for 5 min. Insoluble material was removed by centrifugation at 10,000 g for 30 min. The peptic-tryptic digest of zein (Pt-Z) was finally freeze-dried and stored at −20°C.
Cell culture
The mouse monocyte/macrophage cell line RAW 264.7 was cultured at 37°C in humidified 5% CO2/95% air in Dulbecco's Modified Eagle's Medium (DMEM) containing 10% foetal bovine serum, 2 mM glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin, 25 mM Hepes and 5 mM sodium pyruvate. The cells were plated in 24 culture wells at a density of 2.5×105 cells/ml per well or 10 cm diameter culture dishes at a density of 3×106 cells/ml per dish and allowed to adhere for 2 h. Thereafter the medium was replaced with fresh medium and cells were activated with IFN-γ (25 U/ml). Pt-G (50, 100, 200, 400 and 800 μg/ml), G (50, 100, 200, 400 and 800 μg/ml), bovine serum albumin (BSA; 50, 100, 200, 400 and 800 μg/ml), Pt-Z (50, 100, 200, 400 and 800 μg/ml), Z (50, 100, 200, 400 and 800 μg/ml), pyrrolidine dithiocarbamate (PDTC; 0.1, 1 and 10 μM) or N-α-para-tosyl-L-lysine chloromethyl ketone (TLCK; 1, 10 and 100 μM) were added to the cells 5 min after IFN-γ challenge, alone or in combination. The cell viability was determined by using 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) conversion assay (D'Acquisto et al. 2001). Briefly, 100 μl MTT (5 mg/ml in complete DMEM) was added and the cells were incubated for an additional 3 h. After this time point the cells were lysed and the dark blue crystals solubilised with 500 μl of a solution containing 50% (v:v) N,N-dimethylformamide, 20% (w:v) SDS with an adjusted pH of 4.5. The optical density (OD) of each well was measured with a microplate spectrophotometer (Titertek Multiskan MCCC/340) equipped with a 620 nm filter. The cell viability in response to treatment with test compounds was calculated as % dead cells=100−(OD treated/OD control)×100.
Nitrite determination
NO was measured as nitrite (NO− 2, nmol/106 cells) accumulated in the incubation medium after 24, 48 and 72 h. A spectrophotometric assay based on the Griess reaction was used (D'Acquisto et al. 2001). Briefly, Griess reagent (1% sulphanilamide, 0.1% naphthylethylenediamine in phosphoric acid) was added to an equal volume of cell culture supernatant and the absorbance at 550 nm was measured after 10 min. The nitrite concentration was determined by reference to a standard curve of sodium nitrite.
Cytosolic and nuclear extracts
Cytosolic and nuclear extracts of macrophages stimulated for 1, 3, 6, 24, 48 and 72 h with IFN-γ (25 U/ml) in presence or absence of Pt-G (50, 100, 200, 400 and 800 μg/ml), G (50, 100, 200, 400 and 800 μg/ml), PDTC (0.1, 1 and 10 μM) or TLCK (1, 10 and 100 μM) were prepared as previously described with some modification (D'Acquisto et al. 2001). Briefly, harvested cells (3×106) were washed two times with ice-cold PBS and centrifuged at 180 g for 10 min at 4°C. The cell pellet was resuspended in 100 μl of ice-cold hypotonic lysis buffer (10 mM Hepes, 10 mM KCl, 0.5 mM phenylmethylsulphonyfluoride, 1.5 μg/ml soybean trypsin inhibitor, 7 μg/ml pepstatin A, 5 μg/ml leupeptin, 0.1 mM benzamidine, 0.5 mM dithiothreitol) and incubated on ice for 15 min. The cells were lysed by rapid passage through a syringe needle for five or six times and the cytoplasmic fraction was then obtained by centrifugation for 1 min at 13,000 g. The supernatant containing the cytosolic fraction was removed and stored at −80°C. The nuclear pellet was resuspended in 60 μl of high salt extraction buffer (20 mM Hepes pH 7.9, 10 mM NaCl, 0.2 mM EDTA, 25% v/v glycerol, 0.5 mM phenylmethylsulphonyfluoride, 1.5 μg/ml soybean trypsin inhibitor, 7 μg/ml pepstatin A, 5 μg/ml leupeptin, 0.1 mM benzamidine, 0.5 mM dithiothreitol) and incubated with shaking at 4°C for 30 min. The nuclear extract was then centrifuged for 15 min at 13,000 g and supernatant was aliquoted and stored at −80°C. Protein concentration was determined by Bio-Rad (Milan, Italy) protein assay kit.
Electrophoretic mobility shift assay
Double stranded oligonucleotides containing the NF-κB (5′-CAA CGGCAGGGGAATCTCCCTCTCCTT-3′), IRF-1 (5′-GGAAGCGAAAATGAAATTGACT-3′) and STAT-1α (5′-CATGTTATGCATATTCCTGTAAGTG-3′) recognition sequences were endlabelled with 32P-γ-ATP. Nuclear extracts containing 5 μg protein were incubated for 15 min with radiolabeled oligonucleotides (2.5–5.0×104 cpm) in 20 μl reaction buffer containing 2 μg poly dI-dC, 10 mM Tris-HCl (pH 7.5), 100 mM NaCl, 1 mM EDTA, 1 mM DTT, 10% (v/v) glycerol. The specificity of the DNA/protein binding was determined by competition reaction in which a 50-fold molar excess of unlabeled wild-type, mutant or Sp-1 oligonucleotide was added to the binding reaction 15 min before addition of radiolabeled probe. In supershift assay, antibodies reactive to p50 or p65 proteins were added to the reaction mixture 15 min before the addition of radiolabeled NF-κB probe. Nuclear protein-oligonucleotide complexes were resolved by electrophoresis on a 6% non-denaturing polyacrylamide gel in 1× TBE buffer at 150 V for 2 h at 4°C. The gel was dried and autoradiographed with intensifying screen at −80°C for 20 h. Subsequently, the relative bands were quantified by densitometric scanning of the X-ray films with a GS-700 Imaging Densitometer (Bio-Rad, Milan, Italy) and a computer program (Molecular Analyst; IBM).
Western blot analysis
Immunoblotting analysis of anti-iNOS, anti-IκBα, anti-p50 and anti-p65 was performed on cytosolic or nuclear fraction. Cytosolic and nuclear fraction proteins were mixed with gel loading buffer (50 mM Tris, 10% SDS, 10% glycerol, 10% 2-mercaptoethanol, 2 mg/ml of bromophenol) in a ratio of 1:1, boiled for 3 min and centrifuged at 10,000 g for 5 min. Protein concentration was determined and equivalent amounts (50 μg) of each sample were electrophoresed in a 8% discontinuous polyacrylamide minigel. The proteins were transferred onto nitro-cellulose membranes, according to the manufacturer's instructions (Bio-Rad). The membranes were saturated by incubation at 4°C overnight with 10% non-fat dry milk in PBS and then incubated with (1:1000) anti-iNOS, anti-IκBα, anti-p50 and anti-p65 for 1 h at room temperature. The membranes were washed three times with 0.05% Triton 100X in PBS and then incubated with anti-rabbit or anti-goat immunoglobulins coupled to peroxidase (1:1000). The immunocomplexes were visualised by the ECL chemiluminescence method (Santa Cruz, Milan, Italy). The membranes were stripped and re-probed with β-actin antibody to verify equal loading of proteins. Subsequently, the relative expression of iNOS in cytosolic fraction was quantified by densitometric scanning of the X-ray films with a GS 700 Imaging Densitometer (Bio-Rad) and a computer programme (Molecular Analyst, IBM).
Transfection and assay of CAT activity
Cells (1.5×105) were seeded overnight in 60 mm culture dishes in complete medium and transfected in triplicate using FuGENE 6 (Roche Molecular Biochemicals) at about 30–50% confluency on the day of the experiment. 4 μg of piNOS CAT1 plasmid (Weisz et al. 1996) and 0.5 μg of the luciferase gene under the control of the cytomegalovirus enhancer (CMV-Luc) were mixed with 6 μl of FuGENE 6 in 100 μl of medium. The mixture was incubated at room temperature for 45 min and then added to cells. After 24 h of transfection the cells were treated with IFN-γ (25 U/ml), G (800 μg/ml), Z (800 μg/ml), PDTC (10 μM). After an additional 24 h the cells were harvested, lysed and luciferase activity was measured in according to the manufacturer's protocol by a luminometer (EG&G Berthold). The samples normalised for luciferase activity were analysed for CAT activity following a previous protocol based on TLC separation of acetylated [14C] chloramphenicol. The amount of acetylated substrate was quantified in a STORM-840 radioactivity detection system.
Statistics
Results were expressed as the means ± SEM of n experiments. Statistical significance was calculated by one-way analysis of variance (ANOVA) and Bonferroni-corrected p-value for multiple comparison test. The level of statistically significant difference was defined as p<0.05. Linear associations between variables were assessed by the use of standard-least-square linear regression. Correlation coefficients (r) were presented as measures of linear association for regression relationship. The fold increase was calculated by dividing the combination value by sum of individual values.
Reagents
Recombinant mouse interferon-γ was from Vinci-Biochem (Florence, Italy). 32P-γ-ATP was from Amersham (Milan, Italy). Poly dI-dC was from Boehringer-Mannheim (Milan, Italy). Anti-p50, anti-p65, anti-iNOS, anti-β-actin and anti-IκBα antibodies was from Santa Cruz (Milan, Italy). Phosphate buffer saline was from Celbio (Milan, Italy). Oligonucleotide synthesis was performed to our specifications by Tib Molbiol (Boehringer-Mannheim, Genova, Italy). Non-fat dry milk was from Bio-Rad (Milan, Italy). DL-dithiothreitol, pepstatin A, leupeptin, benzamidine, phenylmethylsulfonilfluoride were from Applichem (Darmstadt, Germany). BSA, MTT, PDTC and TLCK as well as other reagents were from Sigma (Milan, Italy).
Results
Effect of Pt-G and G on nitrite production by RAW 264.7 cells stimulated with IFN-γ for 24 h
The nitrite production by unstimulated cells was undetectable. The stimulation of cells with IFN-γ (25 U/ml) for 24 h resulted in an accumulation of nitrite in the medium. Addition of Pt-G (50, 100, 200, 400 and 800 μg/ml) or G (50, 100, 200, 400 and 800 μg/ml) to the cells increased significantly and in a concentration-dependent manner the nitrite production as compared with IFN-γ alone (Fig. 1). Enhancement of nitrite production by G was greater than that exhibited by Pt-G. In contrast, Pt-G or G added to the cells alone, at the same concentrations, did not elicit the nitrite production (data not shown). BSA, Pt-Z and Z (50, 100, 200, 400 and 800 μg/ml), used as other food antigens, alone or in combination with IFN-γ had no effect (Table 1). All compounds did not affect cell viability (>95%).
Effect of PDTC and TLCK on increase of nitrite production and iNOS protein expression by Pt-G and G in RAW 264.7 macrophages stimulated with IFN-γ for 24 h
Pt-G (800 μg/ml) or G (800 μg/ml), added to the cells together with IFN-γ (25 U/ml), caused an increase of nitrite production (55.4±2.7 and 86.4±3.4, respectively; n=3) as compared with IFN-γ alone (36.0±0.9; n=3). PDTC or TLCK inhibited significantly the increase of nitrite production induced by Pt-G and G (Fig. 2A, B). PDTC (0.1, 1 and 10 μM) or TLCK (1, 10 and 100 μM) caused a reduction of nitrite production induced by IFN-γ alone (by 31.9±2.1%, 37.5±1.4%, 66.8±1.8% and 40.0±2.35%, 49.0±3.0%, 64.0±2.1%, respectively; n=3). Upon stimulation with IFN-γ (25 U/ml) for 24 h, cells expressed high level of iNOS protein expression as compared with untreated cells. Pt-G (800 μg/ml) or G (800 μg/ml), added to the cells together with IFN-γ (25 U/ml), increased iNOS protein expression (by 1.8- and 3.0-fold, respectively). PDTC (10 μM) or TLCK (100 μM) reduced significantly the increase of iNOS protein expression induced by Pt-G (by 80.0±0.1% and 90.0±0.2%, respectively) or G (by 55.1±0.1% and 65.0±0.2%, respectively) (Fig. 3). Pt-G and G alone failed to augment the iNOS protein expression level (data not shown).
Effect of G on iNOS promoter activity in RAW 264.7 cells stimulated with IFN-γ
We examined whether G in association with IFN-γ augmented iNOS gene expression. RAW 264.7 cells were transiently transfected with piNOS CAT1 plasmid. We have tested the promoter activity of the iNOS gene in cells treated with G (800 μg/ml), Z (800 μg/ml), IFN-γ (25 U/ml), PTDC (10 μM) and their combinations. The results normalised by using CMV-Luc as an internal control are reported in Fig. 4 and obtained by quantifying CAT activity in cell extracts. IFN-γ was efficient in enhancing basal transcription of iNOS promoter whereas G and Z alone had no effect. The G+IFN-γ combination treatment led to a higher augmentation of promoter activity compared to IFN-γ alone. This effect was not exhibited by the Z+IFN-γ combination treatment. PDTC inhibited the synergistic induction. Our results indicate that the G increases iNOS expression in IFN-γ-stimulated RAW 264.7 cells through a transcriptional mechanism.
Effect of Pt-G and G on NF-κB/DNA binding activity in RAW 264.7 macrophages stimulated with IFN-γ for 24 h
The effects of Pt-G (800 μg/ml) or G (800 μg/ml) on NF-κB/DNA binding activity in RAW 264.7 macrophages stimulated with IFN-γ (25 U/ml) for 24 h were evaluated by EMSA. A low basal level of NF-κB/DNA binding activity was detected in nuclear proteins from unstimulated macrophages. Conversely, a retarded band was clearly detected following stimulation with IFN-γ. Pt-G and G caused an increase of NF-κB/DNA binding activity (by 1.3- and 1.6-fold, respectively), which was reduced by PDTC (10 μM; 90.0±4.5% and 90.0±3.8%, respectively) or TLCK (100 μM; 73.0±2.0% and 83.5±1.5%, respectively) (Fig. 5A). The composition of the NF-κB complex was determined by competition and supershift experiments. The specificity of NF-κB/DNA binding complex was evident by the complete displacement of NF-κB/DNA binding in the presence of a 50-fold molar excess of unlabelled NF-κB probe in the competition reaction. In contrast a 50-fold molar excess of unlabeled mutated NF-κB probe or Sp-1 oligonucleotide had no effect on DNA-binding activity. The anti-p50 and anti-p65 antibodies clearly gave rise to a characteristic supershift of the retarded complex. Addition of anti-p50+anti-p65 to the binding reaction resulted in a marked reduction of the intensity of NF-κB specific bands, suggesting that the NF-κB complex contained p50 and p65 dimers (Fig. 5B).
Effect of Pt-G and G on degradation of IκBα and nuclear translocation of NF-κB subunits in RAW 264.7 macrophages stimulated with IFN-γ for 24 h
The presence of IκBα in the cytosolic fraction or p50 and p65 subunits in nuclear fraction was examined by immunoblotting analysis. Unstimulated cells as well as cells treated with Pt-G (800 μg/ml) or G (800 μg/ml) alone expressed high levels of IκBα in the cytosolic fraction and basal levels of p50 and p65 in the nuclear fraction. Stimulation of the cells with IFN-γ (25 U/ml) caused a reduction of IκBα band intensity, which almost disappeared in presence of Pt-G (800 μg/ml) or G (800 μg/ml). PDTC (10 μM) or TLCK (100 μM) prevented IκBα degradation (Fig. 6A).Upon the stimulation with IFN-γ, cells exhibited p50 and p65 high nuclear levels which were increased by Pt-G or G. PDTC or TLCK prevented p50 and p65 nuclear translocation (Fig. 6B).
Effect of Pt-G and G on nitrite production, iNOS protein expression and NF-κB/DNA binding activity in RAW 264.7 macrophages stimulated with IFN-γ for 48 and 72 h
The cells stimulated with IFN-γ (25 U/ml) for 48 and 72 h caused nitrite accumulation which was increased in a significant and concentration-dependent manner by Pt-G (50, 100, 200, 400 and 800 μg/ml) or G (50, 100, 200, 400 and 800 μg/ml) (Fig. 7A, B). Interestingly, Pt-G and G at lower concentrations (50 and 100 μg/ml) enhanced significantly (p<0.0001) the nitrite production. In contrast, Pt-G or G added to the cells alone, at the same concentrations, did not elicit the nitrite production (data not shown). Pt-G (800 μg/ml) or G (800 μg/ml) in combination with IFN-γ also increased both iNOS protein expression (by 1.7- and 2.6-fold, at 48 h; by 1.3- and 1.7-fold, at 72 h, respectively) and NF-κB/DNA binding activity (by 1.4- and 1.8-fold, at 48 h; by 1.3- and 1.6-fold, at 72 h, respectively) as compared with IFN-γ alone (Fig. 8A, B). The increase of iNOS protein expression was correlated with NF-κB/DNA binding activity (r=0.99, *p<0.05, Pt-G; r=0.99, *p<0.05, G) at 24, 48 and 72 h.
Effect of Pt-G and G on IRF-1 and STAT-1α DNA/binding activity in RAW 264.7 macrophages stimulated with IFN-γ: comparison with kinetic analysis of NF-κB DNA/binding activity
We investigated the enhancing effect of Pt-G and G on IFN-γ-induced IRF-1 or STAT-1α DNA binding activity. Nuclear extracts from RAW 264.7 cells treated for 1, 3, 6, 24, 48 and 72 h with IFN-γ (25 U/ml) or both IFN-γ and Pt-G (800 μg/ml) or G (800 μg/ml) were subjected to EMSA using the specific binding elements for each transcription factor. As shown in Fig. 9, a low basal level of IRF-1 and STAT-1α/DNA binding activity was detected in nuclear proteins from unstimulated macrophages. Conversely, a retarded band was clearly detected at 1 h after stimulation with IFN-γ. The addition of Pt-G and G to the cells caused an increase of band intensity up to 24 h for IRF-1 and up to 6 h for STAT-1α. In contrast, NF-κB/DNA binding activity was evident at 3 h and increased up to 72 h. Pt-G and G alone did not change the binding activity of IRF-1, STAT-1α and NF-κΒ at time points considered.
Discussion
There is increasing evidence that NO plays important role in the pathogenesis of the histologic changes seen in CD (ter Steege et al. 1997; Beckett et al. 1998; Holmegren Peterson et al. 1998; Beckett et al. 1999; van Straaten et al. 1999). Recently, it has been shown that gluten or gliadin and their proteolytic fragments enhance iNOS mRNA level and NO production by mouse peritoneal macrophages stimulated with IFN-γ (Tuckovà et al. 2000, 2002). The molecular mechanisms by which gluten/gliadin induces iNOS expression and NO production by intestinal mucosa cells in CD and cultured activated macrophages have not been investigated. Here, we report that Pt-G and G were able to increase significantly and in a concentration-dependent manner NO production by RAW 264.7 macrophages stimulated with IFN-γ for 24 h. The increase of NO production by Pt-G and G was associated with an increased expression of iNOS protein compared with IFN-γ alone. In addition, we found that Pt-G and G increased NF-κB/DNA binding activity, IκBα cytosolic degradation and nuclear translocation of p50 and p65 subunits. It is particularly interesting to observe that NF-κB/DNA binding activity as well as iNOS protein expression and NO production were ulteriorly increased by Pt-G and G at 48 and 72 h. In addition, Pt-G and G also at lower concentrations were able to increase significantly NO production. G exhibited greater effects in comparison with Pt-G. These results show that the type and concentration as well as time exposure of gluten derived-peptides induce IFN-γ-stimulated RAW 264.7 cells to produce high levels of NO and suggest a direct toxic action of gliadin in CD. However, Pt-G and G increased iNOS protein expression and NF-κB/DNA binding activity compared with IFN-γ alone. In addition, the G + IFN-γ combination treatment also led to a higher augmentation of iNOS promoter activity compared to IFN-γ alone, suggesting that a synergistic effect of G on IFN-γ-induced iNOS expression occurs at the transcriptional level. Moreover, the NF-κB activation inhibitors, PDTC and TLCK, reduced significantly these effects, thereby indicating that Pt-G and G may modulate iNOS gene expression as co-signal with IFN-γ in RAW 264.7 cells through NF-κB activation. Besides NF-κB, we also investigated the involvement of IRF-1 and STAT-1α in the increase of iNOS expression induced by Pt-G and G in IFN-γ-stimulated RAW 264.7 cells. Interestingly, the kinetics of IRF-1 and STAT-1α activation are rapid and decrease compared with NF-κB activation, which is persistent. It has been reported that STAT-1α and IRF-1 can cooperate with NF-κB to promote synergistically transcriptional activity (Drew et al. 1995; Ohmori et al. 1997; Teng et al. 2002). Although the effect of Pt-G and G on IFN-γ-induced iNOS gene expression seems to depend on the enhanced activity of all three transcription factors, a major role for NF-κB cannot be ruled out. Further studies will be addressed to investigate whether this effect is mediated at the molecular level by a cooperation between transcription factors. Taken together our results show that Pt-G and G cause a time and concentration-dependent increase of IFN-γ-induced NF-κB/DNA binding as well as molecular events downstream of NF-κB activation and suggest a role for gluten/gliadin in maintaining activated NF-κB in infiltrating lamina propria cells of inflamed mucosa of coeliac patients. In CD, it is widely accepted that specific cellular and humoral factors are implicated in morphological and functional changes following gluten challenge in intestinal mucosa (Auricchio et al. 1990). Nevertheless, some reports shown the involvement of non specific immune reaction, caused by direct interaction of gluten of innate immune system (Auricchio et al. 1990; Maiuri et al. 1996; Tuckovà et al. 2000). Gliadin is a lectin that is able to bind glycosylated residues, called "lectinic binding sites" and expressed on various cells, by a non-covalent bound (Kolberg and Sollid 1985; Damjanov 1987; Amore et al. 1994). Other studies have shown that gliadin is able to associate with many proteins, mainly by hydrophobic interactions (Farré Castany et al. 1995; Pittschieler et al. 1994; Tuckovà et al. 2000). It has been reported that different cell types in response to pro-inflammatory stimuli, including IFN-γ, induce the expression of cell surface molecules capable of acting as a potent triggers of intracellular activation signals (Marzio et al. 1997). Since Pt-G and G alone had no effect, it could be hypothesised that IFN-γ induces the expression of macrophage surface molecules able of interacting with Pt-G or G and triggering signal transduction pathway. Moreover, gliadin and other lectin fractions of gluten have been shown to be potent modulators of leukocyte function, enhancing chemotaxis and generation of reactive oxygen species (Roccatello et al. 1990; Amore et al. 1994; Rivabene et al. 1999). Several evidences suggest that NF-κB activation may also be under the control of oxidant/antioxidant balance (Flohè et al. 1997). The antioxidant PDTC is thought to inhibit NF-κB activation by depleting the cells of oxygen radicals, whereas TLCK acts by inhibiting proteasome function and hence IκBα degradation (Sherman et al. 1993; Kim et al. 1995; Epinat and Gilmore 1999). We found that Pt-G and G enhanced IκBα degradation, which was prevented by either PDTC or TLCK suggesting that these compounds inhibit NF-κB/DNA binding activity by stabilising IκBα in IFN-γ -stimulated RAW 264.7 macrophages. Thus, it is conceivable that Pt-G and G in combination with IFN-γ increase NF-κB activation through an oxidant mechanism. Moreover, our results show that PDTC and TLCK are able to reduce the increased iNOS protein expression and NO production by activated macrophages suggesting that NF-κB is responsible for the synergistic effect of Pt-G and G together IFN-γ on NO production. High levels of NO are present in serum and urine of children with CD and correlated with an increased iNOS expression in the small intestine (ter Steege et al. 1997; Beckett et al. 1998; Holmegren Peterson et al. 1998; Beckett et al. 1999; van Straaten et al. 1999). However, the molecular mechanisms by which NO induces, directly or indirectly, injury of the small-intestine in coeliac patients are not clear. Excessively produced NO is known to act as a free radical and cause tissue damage (Liu and Hotchkiss 1995). In conclusion, our study provides evidence that the effect of Pt-G and G on iNOS protein expression in IFN-γ-treated RAW 264.7 cells is mediated through NF-κB and suggests that blockage of NF-κB activation reduces enhancing effect of gluten on NO production in inflamed mucosa of coeliac patients.
References
Amore A, Emancipator SN, Roccatello D, Gianoglio B, Peruzzi L, Porcellini MG, Piccoli G, Coppo R (1994) Functional consequences of the binding of gliadin to cultured rat mesangial cells: bridging immunoglobulin A to cells and modulation of eicosanoid synthesis and altered cytokine production. Am J Kid Dis 23:290–301
Auricchio S, De Ritis G, De Vincenzi M, Magazzù G, Maiuri L, Mancini E (1990) Mannan and oligomers of N-acetylglucosamine protect intestinal mucosa of celiac patients with active disease from in vitro toxicity of gliadins peptides. Gastroenterology 99:973–978
Beckett CG, Dell'Olio D, Shidrawi RG, Rosen-Bronson S, Ciclitira PJ (1998) The detection and localization of inducible nitric oxide synthase production in the small intestine of patients with coeliac disease. Eur J Gastroenterol Hepat 11:529–535
Beckett CG, Dell'Olio D, Shidrawi RG, Rosen-Bronson S, Ciclitira PJ (1999) Gluten-induced nitric oxide and pro-inflammatory cytokine release by cultured coeliac small intestinal biopsies. Eur J Gastroenterol Hepatol 11:529–535
Chu SC, Marks-Konczalik J, Wu HP, Banks TC, Moss J (1998) Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters. Biochem Biophys Res Commun 248:871–878
D'Acquisto F, de Cristofaro F, Maiuri MC, Tajana G, Carnuccio R (2001) Protective role of nuclear factor kappaB against nitric oxide-induced apoptosis in J774 macrophages. Cell Death Diff 8:144–151
Damjanov I (1987) Lectin cytochemistry and histochemistry. Lab Invest 57:5–20
De Ritis G, Occorsio P, Auricchio S, Gramenzi F, Morisi G, Silano V (1979) Toxicity of wheat flour proteins and protein-derived peptides for in vitro developing intestine from rat fetus. Pediatr Res 13:1255–1261
Drew PD, Franzoso G, Becker KG, Bours V, Carlson LM, Siebenlist U, Ozato K (1995) NFκB and interferon regulatory factor 1 physically interact and synergistically induce major histocompatibility class I gene expression. J Interferon Cytokine Res 15:1037–1045
Eberhardt W, Kunz D, Hummel R, Pfeilschifter J (1996) Molecular cloning of the rat inducible nitric oxide synthase gene promoter. Biochem Biophys Res Commun 223:752–756
Epinat J-C, Gilmore TD (1999) Diverse agent act at multiple levels to inhibit the Rel/NF-κB signal transduction pathway. Oncogene 18:6896–6909
Farré Castany MA, Kocna P, Tlaskalová-Hogenová H (1995) Binding of gliadin to lymphoblastoid, myeloid and epithelial cell lines. Folia Microbiol 40:431–435
Flohè L, Brigelius-Flohe R, Saliou C, Traber MG, Packer L (1997) Redox regulation of NF-κB activation. Free Radic Biol Med 22:1115–1126
Gao J, Morrison DC, Parmely TJ, Russell SW, Murphy WJ (1997) An interferon-gamma-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-gamma and lipopolysaccharide. J Biol Chem 272:1226–1230
Holmegren Peterson K, Fälth-Magnusson K, Magnusson K-E, Stenhammar L, Sundqvist T (1998) Children with celiac disease express inducible nitric oxide synthase in the small intestine during gluten challenge. Scand J Gastroenterol 33:939–943
Kamijo R, Harada H, Matsuyama T, Bosland M, Gerecitano J, Shapiro D, Le J, Koh SI, Kimura T, Green SJ (1994) Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263:1612–1615
Kim H, Lee HS, Chang KT, Ko TH, Baek KJ, Kwon NS (1995) Chloromethyl ketones block induction of nitric oxide synthase in murine macrophages by preventing activation of nuclear factor-κB. J Immunol 154:4741–4748
Kim YM, Lee BS, Yi KY, Paik SG (1997) Upstream NF-kappaB site is required for the maximal expression of mouse inducible nitric oxide synthase gene in interferon-gamma plus lipopolysaccharide-induced RAW 264.7 macrophages. Biochem Biophys Res Commun 236:655–660
Kolberg J, Sollid LM (1985) Lectin activity of gluten identified as wheat germ agglutinin. Biochem Biophys Res Comm 130:867–872
Kontakou M, Przemioslo RT, Sturgess RP, Limb AG, Ciclitira PJ (1995) Expression of tumor necrosis factor-alfa, interleukin-6, and interleukin-2 mRNA in the jejunum of patients with coeliac disease. Scand J Gastroenterol 30:456–463
Liu RH, Hotchkiss JH (1995) Potential genotoxicity of chronically elevated nitric oxide: a review. Mutat Res 339:73–89
Maiuri L, Troncone R, Mayer M, Coletta S, Picarelli A, De Vincenzi M, Pavone V, Auricchio S (1996) In vitro activities of A-gliadin related synthetic peptides: damaging affect on the atrophic coeliac mucosa and activation of mucosal immune response in the treated coeliac mucosa. Scand J Gastroenterol 31:247–253
Marsh MN (1992) Gluten, major histocompatibility complex, and the small intestine. Gastroenterology 102:330–354
Martin E, Nathan C, Xie QW (1994) Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J Exp Med 180:977–984
Marzio R, Jirillo E, Ransijn A, Mauel J, Corradin SB (1997) Expression and function of the early activation antigen CD 69 in murine macrophages. J Leukoc Biol 62:349–355
Nilsen EM, Lundin KEA, Krajci P, Scott H, Sollid LM, Brandtzaeg P (1995) Gluten specific, HLA-DQ restricted T cells from celiac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon-gamma. Gut 37:766–776
Ohmori Y, Schreiber RD, Hamilton TA (1997) Synergy between interferon-γ and tumor necrosis factor-α in transcriptional activation is mediated by cooperation between signal transducer and activated of transcription 1 and nuclear factor κB. J Biol Chem 272:14899–14907
Pender SLF, Lionetti P, Murch SH, Wathan N, MacDonald TT (1996) Proteolytic degradation of intestinal mucosa extracellular matrix after lamina propria T cell activation. Gut 39:284–290
Pittschieler K, Ladinser B, Petell JK (1994) Reactivity of gliadin and lectins with celiac intestinal mucosa. Pediatr Res 36:635–641
Przemioslo R, Kontakou M, Nobili V, Ciclitira PJ (1994) Detection of interferon-gamma mRNA in the mucosa of patients with coeliac disease by in situ hybridization. Gut 35:1398–1404
Rivabene R, Mancini E, De Vincenzi M (1999) In vitro cytotoxic effect of wheat gliadin-derived peptides on the Caco-2 intestinal cell line in associated with intracellular oxidative imbalance: implications for coeliac disease. Biochem Biophys Acta 1453:152–160
Roccatello D, Amprimo MC, Coppo R, Cavalli G, Quattrocchio G, Gianoglio B, Ferrero A, di Mauro C, Sena LM, Piccoli G (1990) Influence of gluten-derived fractions on chemiluminescence production by human neutrophils. J Biolumin Chemilumin 5:161–164
Shan L, Molberg Ø, Parrot I, Hausch F, Ferda F, Gray GM, Sollid LM, Khosla C (2002) Structural basis for gluten intolerance in celiac sprue. Science 297:2275–2279
Sherman MP, Aeberhard EE, Wong VZ, Griscavage JM, Ignarro LJ (1993) Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages. Biochem Biophys Res Commun 191:1301–1308
Sollid LM (2000) Molecular basis of celiac disease. Ann Rev Immunol 18:53–81
Teng X, Zhang H, Snead C, Catravas J (2002) Molecular mechanisms of iNOS induction by IL-1β and IFN-γ in rat aortic smooth muscle cells. Am J Physiol Cell Physiol 282:C144–C152
Ter Steege J, Buurman W, Arends JW, Forget P (1997) Presence of inducible nitric oxide synthase, nitrotyrosine, CD68, and CD14 in the small intestine in celiac disease. Lab Invest 77:29–36
Tuckovà L, Flegelová Z, Tlaskalová-Hogenová H, Zìdek Z (2000) Activation of macrophages by food antigens: enhancing effect of gluten on nitric oxide and cytokine production. J Leukoc Biol 67:312–318
Tuckovà L, Novotna J, Novak P, Flegelová Z, Kveton T, Jelinkova L, Zìdek Z, Man P, Tlaskalová-Hogenová H (2002) Activation of macrophages by gliadin fragments: isolation and characterization of active peptide. J Leukoc Biol 71:625–631
Van Straaten EA, Koster-Kamphuis L, Bovee-Oudenhoven IM, van der Meer R, Forget P-P (1999) Increased urinary nitric oxide oxidation products in children with active coeliac disease. Acta Paediatr 88:528–531
Weisz A, Oguchi S, Cicatiello L, Esumi H (1994) Dual mechanism for the control of inducible-type NO synthase gene expression in macrophages during activation by interferon-γ and bacterial lipopolysaccharide. J Biol Chem 269:8324–8333
Weisz A, Cicatiello L, Esumi H (1996) Regulation of the mouse inducible-type nitric oxide synthase gene promoter by interferon-γ, bacterial lipopolysaccharide and NG-monomethyl-L-arginine. Biochem J 316:209–215
Xie QW, Whisnant R, Nathan C (1993) Promoter of mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon-γ and bacterial lipopolysaccharide. J Exp Med 177:1779–1784
Acknowledgements
This research was supported by a grant from the Italian government (PRIN 2002). We thank Prof. Hiroyasu Esumi (National Cancer Center Research Institute East, Chiba, Japan) and Prof. Alessandro Weisz (Istituto di Patologia generale e Oncologia, Seconda Università di Napoli, Naples, Italy) for their generous gift of plasmid used in this paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maiuri, M.C., De Stefano, D., Mele, G. et al. Gliadin increases iNOS gene expression in interferon-γ-stimulated RAW 264.7 cells through a mechanism involving NF-κB. Naunyn-Schmiedeberg's Arch Pharmacol 368, 63–71 (2003). https://doi.org/10.1007/s00210-003-0771-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-003-0771-y